首页> 美国卫生研究院文献>Drug Design Development and Therapy >Preparation and characterization of genipin-cross-linked silk fibroin/chitosan sustained-release microspheres
【2h】

Preparation and characterization of genipin-cross-linked silk fibroin/chitosan sustained-release microspheres

机译:Genipin交联的丝素蛋白/壳聚糖缓释微球的制备与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the effects of distinct concentrations of genipin and silk fibroin (SF):chitosan (CS) ratios on the formation of SF–CS composite microspheres. We selected microspheres featuring an SF:CS ratio of 1:1, encapsulated various concentrations of bovine serum albumin (BSA), and then compared their encapsulation efficiency and sustained-release rate with those of pure CS microspheres. We determined that the following five groups of microspheres were highly spherical and featured particle sizes ranging from 70 μm to 147 μm: mass ratio of CS:SF =1:0.5, 0.1 g or 0.5 g genipin; CS:SF =1:1, 0.05 g or 1 g genipin; and CS:SF =1:2, 0.5 g genipin. The microspheres prepared using 1:1 CS:SF ratio and 0.05 g genipin in the presence of 10 mg, 20 mg, and 50 mg of BSA exhibited encapsulation efficiencies of 50.16%±4.32%, 56.58%±3.58%, and 42.19%±7.47%, respectively. Fourier-transform infrared spectroscopy (FTIR) results showed that SF and CS were cross-linked and that the α-helices and random coils of SF were converted into β-sheets. BSA did not chemically react with CS or SF. Moreover, thermal gravimetric analysis (TGA) results showed that the melting point of BSA did not change, which confirmed the FTIR results, and X-ray diffraction results showed that BSA was entrapped in microspheres in a noncrystalline form, which further verified the TGA and FTIR data. The sustained-release microspheres prepared in the presence of 10 mg, 20 mg, and 50 mg of BSA burst release 30.79%±3.43%, 34.41%±4.46%, and 41.75%±0.96% of the entrapped BSA on the 1st day and cumulatively released 75.20%±2.52%, 79.16%±4.31%, and 89.04%±4.68% in 21 days, respectively. The pure CS microspheres prepared in the presence of 10 mg of BSA burst release 39.53%±1.76% of BSA on the 1st day and cumulatively released 83.57%±2.33% of the total encapsulated BSA in 21 days. The SF–CS composite microspheres exhibited higher sustained release than did the pure CS microspheres, and thus these composite microspheres might function as a superior drug carrier.
机译:我们报告了不同浓度的京尼平和丝素蛋白(SF):壳聚糖(CS)比例对SF–CS复合微球形成的影响。我们选择了SF:CS比率为1:1的微球,包封了各种浓度的牛血清白蛋白(BSA),然后将它们的包封效率和缓释率与纯CS微球进行了比较。我们确定以下五组微球为高度球形,其粒径范围为70μm至147μm:CS:SF的质量比= 1:0.5、0.1 g或0.5 g京尼平; CS:SF = 1:1、0.05 g或1 g genipin;和CS:SF = 1:2,0.5 g京尼平。在10 mg,20 mg和50 mg BSA的存在下,以1:1 CS:SF比和0.05 g genipin制备的微球的包封效率分别为50.16%±4.32%,56.58%±3.58%和42.19%±分别为7.47%。傅立叶变换红外光谱(FTIR)结果表明SF和CS交联,并且SF的α螺旋和无规卷曲转变为β片。 BSA不会与CS或SF发生化学反应。此外,热重分析(TGA)结果表明BSA的熔点没有变化,这证实了FTIR结果; X射线衍射结果表明BSA以非晶态形式被包埋在微球中,这进一步验证了TGA和FTIR数据。在存在10 mg,20 mg和50 mg BSA的情况下制备的持续释放微球在第一天释放了30.79%±3.43%,34.41%±4.46%和41.75%±0.96%的包埋BSA。 21天分别释放75.20%±2.52%,79.16%±4.31%和89.04%±4.68%。在10mg BSA存在下制备的纯CS微球在第一天破裂释放BSA的39.53%±1.76%,并在21天内累积释放了总包封的BSA的83.57%±2.33%。 SF-CS复合微球比纯CS微球表现出更高的持续释放,因此这些复合微球可能充当优良的药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号